Gastroenterologist Lists Overlooked Bloating Triggers in Washington Post Report
Bloating that resists the usual suspects — lactose, fructose, excess fiber — often traces back to sugar-free products, onions, gluten, prebiotics, and raffinose, a gastroenterologist told The Washington Post in a recent rundown of overlooked dietary triggers.
The item leads a batch of gastroenterology and hepatology news, spanning colorectal cancer screening in younger adults, eating disorder risk in celiac disease, and surgical safety data in pancreatic cancer.
- Common “sneaky” causes of bloating include sugar-free products, onions, gluten, prebiotics, and raffinose, per a gastroenterologist writing in The Washington Post.
- A modeling study in JAMA Network Open found early naltrexone and behavioral therapy for alcohol use disorder is cost-effective in patients with alcohol-associated liver disease by lowering the risk of progression to cirrhosis and liver-related mortality.
- A Swedish cohort study linked a celiac disease diagnosis with an increased risk of eating disorders, also reported in JAMA Network Open.
- Open questions remain on whether fecal immunochemical testing works as well in symptomatic adults under 50 as in older patients, and on hyperammonemia’s role in infection-related hospitalizations in cirrhosis.
Hidden Triggers Behind a Common Complaint
The Washington Post report framed the list as causes patients and clinicians frequently miss. Sugar-free products, onions, gluten, prebiotics, and raffinose each made the gastroenterologist’s list of offenders. The piece did not quantify how often each trigger explains symptoms, and neither outlet reported prevalence figures.
For patients with persistent distension despite dietary adjustment, the practical step the reporting points to is evaluation by a gastroenterologist rather than repeated self-directed elimination diets.
Screening Question for Adults Under 50
Another item spotlights a screening question that remains unanswered: does fecal immunochemical testing (FIT) diagnose colorectal cancer (CRC) with the same accuracy in symptomatic adults under 50 as it does in those who are older? The question appears in Gut. The material presented it as an open question rather than a settled finding, and no accuracy figures were reported in the material.
The question matters because FIT is a widely used test. Patients who receive a negative FIT result may warrant discussion with a gastroenterologist about whether further evaluation is appropriate — a conversation the reporting frames as a live clinical debate, not a settled protocol change.
Swedish Study Links Celiac Diagnosis to Eating Disorder Risk
A cohort study from Sweden, published in JAMA Network Open, found that a celiac disease diagnosis was associated with an increased risk for eating disorders. The material did not report the cohort size, the magnitude of the association, or the funding source for the study.
The association creates a practical monitoring problem: patients managing a strict gluten-free diet may develop disordered eating patterns around food restriction.
Modeling Shows Early Alcohol Treatment Is Cost-Effective for Liver Disease
Modeling data in JAMA Network Open suggested that early naltrexone and behavioral interventions for alcohol use disorder in patients with alcohol-associated liver disease (ALD) are cost-effective, by decreasing the risk of progression to cirrhosis and liver-related mortality. As a modeling study, the finding projects cost-effectiveness rather than demonstrating it in a trial, and the material did not report funding details.
In a separate Gut report, investigators observed that shifts in immunoglobulin A (IgA)-linked gut microbiota and circulating IgA tracked with how severe the disease was. The same journal carried the new guidelines from the British Society of Gastroenterology on investigating suspected liver disease.
Retrospective data published in Hepatology showed that hyperammonemia in patients with cirrhosis — along with overt hepatic encephalopathy — is linked with an increased risk of bacterial infection-related hospitalizations. The retrospective design limits causal inference, and no hospitalization rates were reported in the material.
Robotic Pancreas Surgery Matches Open Surgery Safety at Expert Centers
According to a randomized-trial meta-analysis in Lancet Gastroenterology & Hepatology, robotic pancreatoduodenectomy carried out at high-volume, experienced centers stands as a safe alternative to the open approach with respect to major complications, 90-day mortality, and time to functional recovery. The analysis was restricted to experienced centers, a limitation the journal’s framing makes explicit.
On the inflammatory bowel disease front, a study from a single center, appearing in Inflammatory Bowel Diseases, indicated that cyclosporine could act as a bridge to advanced therapies such as vedolizumab (Entyvio) or ustekinumab (Stelara) for patients with corticosteroid-resistant acute severe ulcerative colitis who had previously been exposed to biologics. The single-center design means the finding awaits broader confirmation.
A team from Spain, likewise publishing in Inflammatory Bowel Diseases, endorsed intestinal ultrasound as a noninvasive way to detect Crohn’s disease recurrence after ileocecal or right-sided colonic resection. Gastro Hep Advances, meanwhile, examined the clinical pathways of pediatric intestinal neuronal dysplasia, and experts in the American Journal of Gastroenterology reviewed the evolving literature on abelchia, the inability to belch.
One Year After a Transplant
Bernie Kosar marked the 1-year anniversary of his liver transplant and said he feels “happily surprised”, the Associated Press reported. The anniversary fell within the same news cycle as the research items above, and the AP report did not detail his post-transplant regimen or clinical course.
For patients facing transplant evaluation or complex hepatology care, the specialists best positioned to weigh these findings — hepatologists, transplant surgeons, and IBD specialists — remain the appropriate first contact, and the journals cited here are where each question will be settled.
The Paper that carried the gastroenterologist’s list of bloating triggers has a long history with consequential reporting.
Founded in 1877 in Washington, D.C., The Washington Post published the Pentagon Papers in 1971, spurring opposition to the Vietnam War, and its reporters Bob Woodward and Carl Bernstein led the investigation into the Watergate break-in that led to President Richard Nixon’s 1974 resignation. The paper has won 76 Pulitzer Prizes, second only to The New York Times.
In October 2013, the Graham family sold The Washington Post to Nash Holdings, a holding company owned by Jeff Bezos, for US$250 million. Today the paper is considered a newspaper of record in the United States and operates one of the few remaining foreign bureaus among American newspapers, with international news hubs in London and Seoul.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.